İn vitro glukoz kataraktı oluşturulmuş tavşan lenslerindeki glutatyon ve lipid peroksidasyon düzeylerine taurin'in etkisi

Bu çalışmamızda, taurinin antikataraktojenik etkiye sahip olup olmadığını in vitro glukoz kataraktı oluşturulmuş tavşan lenslerindeki redükte glutatyon (GSH) ve lipid peroksidasyon (LPO) düzeylerine göre saptamaya çalıştık. Bu amaçla, lens örnekleri korteks ve nükleus olarak iki kısıma ayrıldı; daha sonra kontrol, katarakt ve taurin çalışma grupları başlıkları altında GSH ve LPO düzeyleri belirlendi. Bulgularımıza göre, katarakt ve taurin gruplarına ait nükleus örneklerindeki GSH düzeyleri kontrollere kıyasla anlamlı bir şekilde değişmemiştir (sıra ile p=0.413 ve p= 0.792); ancak korteks örneklerinde katarakt grubunun GSH düzeyleri kontrollere kıyasla anlamlı bir şekilde azalmıştır (p=0.033). Korteks örneklerinin taurin grubundaki GSH düzeyleri ise kontrollere kıyasla farklı değildir (p=0.295). Nükleus örneklerinin kontrol, katarakt ve taurin gruplarına ait LPO düzeyleri arasında anlamlı bir farklılık yokken, korteks örneklerinin katarakt gruplarında kontrollere kıyasla LPO düzeylerinin anlamlı bir şekilde arttığı dikkat çekmektedir (p=0.022). Diğer yandan taurin grubunda elde edilen LPO düzeyleri kontrollere oldukça yakın sonuçlar vermiştir. Taurin grubunun GSH ve LPO sonuçlarına göre, lens membran lipidlerini oksidatif hasara karşı koruduğu gözlenmektedir. Sonuç olarak, taurinin antikataraktojenik bir madde olduğu söylenebilir.

The effects of taurine on the levels of glutathione and lipid peroxidation on in vitro glucose induced cataractous rabbit lenses

In this our study, we try to determine whether taurine has anticataractogenic action by the levels of glutathione (GSH) and lipid peroxidation (LPO) in vitro glucose-catarct induced rabbit lenses. With this aim, lens samples were divided into two parts as cortex and nucleus, then the GSH and LPO levels were determined under the headings of control, cataract and taurine study groups. According to our results, in the nucleus samples the GSH levels in the cataract and taurine groups showed no remarkable differences as compared to the controls (respectively p=0.413 and p=0.792), however, in the cortex samples the GSH levels in the cataract group decreased significantly relative to the controls (p=0.033). There was no considerable difference between the GSH levels in the taurine and the control groups of the cortex samples (p=0.295). Concerning the LPO levels, the control, cataract and taurine groups of the nucleus samples displayed no significant differences, whereas in the cortex samples, the cataract group was found to have significantly increased LPO levels as compared to the controls (p=0.022). On the other hand, LPO levels of the taurine group tended to yield similar results to those of the control group. According to GSH and LPO results in the taurine groups, it can be postulated that taurine may protect lens membrane lipids against oxidative destruction. In conclusion, it may be postulated that taurine is an anticataractogenic substance.

___

  • 1. Roth E, Spittler A, Oehler R, Glutamin: VVİrkungen auf das immunosystem, auf Eiweisshaushalt und Darmfunktionen. Wien Klin VVochenschr 1996; 108(21): 669-76.
  • 2. Roth E, Kamer J, Intracellular amino acid concentrations in various disease states. Infusionsther Klin Ernahr 1987; 14(4): 147-50.
  • 3. Fischer CP, Bode BP, Abcoouvver SF. Lukaszevvicz GC, Souba WW, Hepatic uptake of glutamine and other aminoacids during infection and inflammation. Shock 1995: 3(5): 315-22.
  • 4. Patience JF, A revievv of the role of acid-base balance in amino acid nutrition. J Anim Sci 1990; 68(2): 398-408.
  • 5. Halavva I, Baig S, Oureshi GA, Use of high performance liquid chromatography in defining the abnormalities in the free amino acid patterns in the cerebrospinal fluid of patients with aseptic menengitis. Biomed Chromatogr 1991; 5(5): 216-20.
  • 6. Bhagavon NV, A Comprehensive Revievv, New York, JB Lipincott Company, 1974.
  • 7. VVİlliams BD, Chinkes DL. VVolfe RR, Alanine and glutamine kinetics at rest and during exercise in humans. Med Sci Sports Exerc 1998: 30(7): 1053-58.
  • 8. Collins FS, Summer GK, Determination glutamine and glutamic acid in bioiogicai fiuids by gas chromatography. J Chromatogr 1978; 145:456-463.
  • 9. Nahorski SR, Fluorometric measurment of glutamine and asparagine using at enzymic methods. Anal Biochem 1971; 42: 136-142.
  • 10. Hofford JM, Milakofsky L, Vogel WH et al., The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels. Am Rev Respir Dis 1990; 141 (4 Pt 1) : 902-8.
  • 11. Stahl E, Thin Layer Chromatography. New York, Springer-Verlac Company, 1969; 583-584.
  • 12 . Esser K, Ein dunnschichromatographisches verfahren zur quantativen bestimmung von aminosauren und aminozuckern im mikromasstab. J Chromatogr 1965; 18:414-416.
  • 13. Voight S, Solle M, Konitzer K, Dünnschichtomatographicce Abitrenung von GABA aus hir naxtrakten. J Chromatogr 1962; 9: 369- 371.
  • 14. VVollenvveber P, Dünschicht-Chromatographische trenungen an cellulose-schicten. J Chromatogr 1962; 9: 372-3
  • 15. Darmaun D, Mattheus DE, Bier DM, Glutamine and glutamate kinetics in humans. Am J Physiol 1986; 251 (E): 117—126.